Description
BLOOD COMPATIBILITY TESTING SERVICES
First action · last action
2025-11-18 · 2025-11-18
Transactions
1
First transaction's obligation
$2,996,700
Base + all options value (sum of deltas)
$2,996,700
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24824D0008
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-11-18+$2,996,700= $2,996,700
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-11-18 | +$2,996,700 | $2,996,700 | BLOOD COMPATIBILITY TESTING SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q301 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826N0684 | VERACYTE, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,730 | FY2026 |
| 36C24826P0831 | UNIVERSITY OF MIAMI | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $178,265 | FY2026 |
| 36C24826N0548 | D & D LABORATORY LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $14,915 | FY2026 |
| 36C24826P0651 | ROCHE DIAGNOSTICS CORPORATION | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $239,858 | FY2026 |
| 36C24826P0221 | REPROSOURCE FERTILITY DIAGNOSTICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $27,500 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24826N0121_3600_36C24824D0008_3600 · retrieved 2026-09-26.